Joel Greenblatt’s AngioDynamics ANGO Stock Holding History

Joel Greenblatt’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,860	Closed	-$295K	–	1016
2021 Q2	$295K	Buy	+10,860	New	+$265K	0.01%	850
2018 Q1	–	Sell	-27,707	Closed	-$461K	–	937
2017 Q4	$461K	Sell	27,707 -21,486	-44%	-$367K	0.01%	723
2017 Q3	$841K	Sell	49,193 -29,828	-38%	-$501K	0.01%	629
2017 Q2	$1.28M	Buy	79,021 +24,140	+44%	+$382K	0.02%	600
2017 Q1	$952K	Sell	54,881 -6,263	-10%	-$105K	0.01%	678
2016 Q4	$1.03M	Buy	61,144 +3,766	+7%	+$62.8K	0.01%	615
2016 Q3	$1.01M	Buy	57,378 +42,530	+286%	+$690K	0.01%	602
2016 Q2	$213K	Buy	+14,848	New	+$186K	﹤0.01%	879
2013 Q4	–	Sell	-16,031	Closed	-$212K	–	960
2013 Q3	$212K	Buy	+16,031	New	+$189K	0.01%	853

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Joel Greenblatt's ANGO Position: Q3 2021 in Review

Joel Greenblatt sold out of AngioDynamics (ANGO) in Q3 2021, closing a stake of 10,860 shares — an estimated $295K sold.

Joel Greenblatt first reported a position in ANGO in Q3 2013 and held it in 9 quarters. The position peaked at $1.28M in Q2 2017. 156 funds tracked by Wall St. Rank hold ANGO as of Q3 2021.

Joel Greenblatt reported no remaining AngioDynamics position as of Q3 2021 after selling out during the quarter.
Joel Greenblatt sold 10,860 AngioDynamics shares in Q3 2021, an estimated $295K.
Joel Greenblatt first reported a position in AngioDynamics in Q3 2013 and held it in 9 quarters.
Joel Greenblatt's AngioDynamics position peaked at $1.28M in Q2 2017.
156 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2021.

Based on Gotham Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.